Skip to content

The metastasis rate of the anterior leaf of the vesicouterine ligament in early-stage cervical cancer and its clinical significance

The metastasis rate of the anterior leaf of the vesicouterine ligament in early-stage cervical cancer and its clinical significance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031789
Enrollment
Unknown
Registered
2020-04-10
Start date
2020-04-15
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

case series:abdominal radical hysterectomy plus pelvic lymphadenectomy

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Cervical squamous cell carcinoma, adenocarcinoma or adenosquamous cell carcinoma were confirmed by histopathology; 2) FIGO 2018 stage is IA2~IIA2; 3) The patients have underwent or are gonging to undergo the abdominal radical with pelvic lymphadenectomy in our hospital; 4) The patient received treatment for the first time; 5) The general status score of the eastern tumor cooperative group (ECOG) was 0 or 1 (full score was 5, the higher the score was, the higher the degree of disability); 6) Complete clinical, surgical and pathological data of the patients; 7) Full consent obtained from the patients.

Exclusion criteria

Exclusion criteria: 1) Dont conform to stage FIGO 2018 IA2-IIA2 or unable to modify the staging according to the 2018 FIGO staging criteria. 2) History of abdominal or pelvic radiotherapy. 3) Evidence of metastatic disease showed by PET-CT, MRI, CT, et al. 4) The surgeon assesses that the patient is not suitable for abdominal extensive hysterectomy or the patient refuses abdominal surgical treatment. 5) With other malignancies. 6) Absence or partial absence of clinical, surgical and pathological data of the patients.

Design outcomes

Primary

MeasureTime frame
The metastasis rate of the anterior leaf of the vesicouterine ligament;

Secondary

MeasureTime frame
the result of immunohistochemistry after staining S100, CD34 and D2-40 in the anterior leaf of the vesciouterine ligament;the distribution and characteristics of the nerve in the anterior leaf of the vesciouterine ligament;the distribution and characteristics of the lymphatic vessels in the anterior leaf of the vesciouterine ligament;The incidence of urinary dysfunction 1 month after surgery;The LCT result (the positive rate of HSIL or ASCUS-H) of the vaginal residue at 6 months after surgery;

Countries

China

Contacts

Public ContactHuaiwu Lu

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

luhuaiwu@163.com+86 18688395806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026